Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy of intensive lipid-lowering therapy with Lipitor on the changes of
characteristics of yellow coronary plaque in subjects with hypercholesteremia accompanying
coronary artery disease